Skip to main content
. 2017 May 3;8(42):71699–71708. doi: 10.18632/oncotarget.17599

Table 3. Pathological features and immunohistochemistry results of certain biomarkers of NENs.

Clinical and Pathological features Total distribution (N=2010) Gastric cardiac NENs (N=234) Gastric body NENs (N=309) Rectal NENs (N=595) Pancreatic NENs (N=633) Other NENs (N=239) P value
n (Positive rate %) n (Positive rate %) n (Positive rate %) n (Positive rate %) n (Positive rate %) n (Positive rate %)
Vascular space involvement 1390 (13.8) 209 (22.0) 252 (19.0) 497 (5.2) 258 (17.4) 174 (15.5) 0.000*
Perineural invasion 1378 (5.2) 207 (5.8) 250 (6.8) 493 (1.8) 256 (9.0) 172 (6.4) 0.000*
Necrosis 1391 (9.1) 208 (13.9) 249 (13.3) 499 (3.8) 266 (11.3) 169 (9.5) 0.000*
Cystic degeneration 1368 (2.6) 204 (1.5) 241 (0.4) 490 (0.8) 266 (9.8) 167 (1.2) 0.000*
Synaptophysin 1296 (90.0) 168 (91.1) 215 (89.3) 410 (88.8) 327 (93.3) 176 (86.9) 0.149
Choromogranin A 1243 (67.6) 148 (62.8) 192 (75.0) 371 (52.3) 376 (81.6) 156 (65.4) 0.000*
CD56 532 (79.7) 94 (80.9) 111 (75.7) 143 (77.6) 117 (89.7) 67 (71.6) 0.021*
Neuron-specific enolase 612 (78.8) 78 (65.4) 99 (67.7) 218 (85.3) 135 (83.7) 82 (79.3) 0.000*
S-100 protein 205 (41.0) 26 (26.9) 33 (45.5) 64 (48.8) 49 (34.7) 33 (42.4) 0.32
CK(AE1/AE3) 940 (79.1) 122 (82.0) 165 (86.1) 300 (82.7) 227 (70.5) 126 (74.6) 0.001*

* Significantly different, using Mantel-Haenszel χ2 test or Fisher's exact tests.